Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (47 quarters reported)
$230M in Q4 2014 → $2.8B now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| SS SPDR S&P 500 ETF Tr Put | 45.7% | Added 62% | 1,711,800 | $1.28B |
| Microsoft Corp Call | 21.2% | New | 1,587,400 | $592M |
| IQ Invesco Qqq Tr Put | 16.7% | Unchanged | 634,755 | $467M |
| Qxo Inc | 11.2% | Added 31% | 18,113,850 | $313M |
| Rxo Inc | 5.3% | Trimmed 47% | 5,355,445 | $148M |
| Aleanna Inc | 0.0% | Unchanged | 490,000 | $147K |
| Aleanna Inc | 0.0% | Unchanged | 27,717 | $80.4K |
| Moneyhero Limited | 0.0% | Unchanged | 895,000 | $37K |
| Calidi Biotherapeutics Inc | 0.0% | Unchanged | 1,042 | $177 |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 13, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Microsoft Corp | New | +1,587,400 | +$592M | 21.2% |
| SS SPDR S&P 500 ETF Tr | Added | +657,100 | +$491M | 45.7% |
| IT Ishares Tr | Exited | −1,469,968 | −$483M | — |
| Rxo Inc | Trimmed | −4,718,173 | −$130M | 5.3% |
| Qxo Inc | Added | +4,255,435 | +$73.5M | 11.2% |
quarter ended March 31, 2026 · filed May 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IT Ishares Tr | New | +1,469,968 | +$483M | 24.7% |
| IT Ishares Tr | Exited | −1,617,000 | −$398M | — |
| IQ Invesco Qqq Tr | New | +634,755 | +$366M | 18.8% |
| SS SPDR S&P 500 ETF Tr | Trimmed | −518,500 | −$337M | 35.1% |
| Qxo Inc | Trimmed | −7,319,000 | −$142M | 13.8% |
| Rxo Inc | Added | +684,829 | +$10M | 7.5% |
| Solid Biosciences Inc | Exited | −961,251 | −$5.42M | — |
quarter ended December 31, 2025 · filed February 13, 2026
quarter ended September 30, 2025 · filed November 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IT Ishares Tr | Added | +1,032,000 | +$250M | 22.5% |
| Rxo Inc | New | +7,266,839 | +$112M | 6.4% |
| LM Liberty Media Corp Del | Exited | −537,051 | −$43.6M | — |
| SS SPDR S&P 500 ETF Tr | Added | +34,000 | +$22.6M | 46.3% |
| Qxo Inc | Added | +1,142,747 | +$21.8M | 24.4% |
| Lakeshore Biopharma Co Ltd | Exited | −489,999 | −$19.6K | — |
| Calidi Biotherapeutics Inc | Exited | −12,499 | −$2.88K | — |
| Calidi Biotherapeutics Inc | New | +1,042 | +$1.58K | — |
quarter ended June 30, 2025 · filed August 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR S&P 500 ETF Tr | Added | +418,500 | +$259M | 53.5% |
| IT Ishares Tr | Trimmed | −900,000 | −$194M | 9.3% |
| Qxo Inc | Trimmed | −3,315,292 | −$71.4M | 33.6% |
| Liberty Broadband Corp | Exited | −529,240 | −$45M | — |
| Springworks Therapeutics Inc | Exited | −728,602 | −$32.2M | — |
| Ascendis Pharma A/s | Exited | −179,872 | −$28M | — |
| Revolution Medicines Inc | Exited | −691,260 | −$24.4M | — |
| Moonlake Immunotherapeutics | Exited | −435,785 | −$17M | — |
| Galapagos Nv | Exited | −656,587 | −$16.5M | — |
| Cytokinetics Inc | Exited | −309,948 | −$12.5M | — |
Showing the 10 largest of 19 changes.
quarter ended March 31, 2025 · filed May 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Liberty Broadband Corp | Trimmed | −1,486,470 | −$126M | 3.4% |
| Argenx Se | Exited | −52,928 | −$32.6M | — |
| LM Liberty Media Corp Del | Trimmed | −379,897 | −$25.9M | 2.2% |
| Qxo Inc | Trimmed | −465,665 | −$6.31M | 25.3% |
| Springworks Therapeutics Inc | Trimmed | −20,150 | −$889K | 2.5% |
| Ascendis Pharma A/s | Trimmed | −5,000 | −$779K | 2.1% |
| Revolution Medicines Inc | Trimmed | −19,000 | −$672K | 1.9% |
| Moonlake Immunotherapeutics | Trimmed | −12,150 | −$475K | 1.3% |
| Galapagos Nv | Trimmed | −18,175 | −$457K | 1.3% |
| Cytokinetics Inc | Trimmed | −8,500 | −$342K | 0.9% |
Showing the 10 largest of 18 changes.
quarter ended December 31, 2024 · filed February 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR S&P 500 ETF Tr | Added | +200,000 | +$117M | 27.0% |
| IT Ishares Tr | Added | +420,000 | +$92.8M | 20.0% |
| LM Liberty Media Corp Del | New | +812,792 | +$55.3M | 3.4% |
| Travere Therapeutics Inc | Exited | −1,782,267 | −$24.9M | — |
| Xencor Inc | New | +660,000 | +$15.2M | 0.9% |
| Acadia Pharmaceuticals Inc | Exited | −905,384 | −$13.9M | — |
| Qxo Inc | Trimmed | −816,956 | −$13M | 24.2% |
| Avidity Biosciences Inc | New | +391,300 | +$11.4M | 0.7% |
| Springworks Therapeutics Inc | Added | +97,900 | +$3.54M | 1.7% |
| Sarepta Therapeutics Inc | Added | +28,400 | +$3.45M | 1.2% |
Showing the 10 largest of 26 changes.
quarter ended September 30, 2024 · filed November 13, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Qxo Inc | New | +25,750,781 | +$406M | 29.5% |
| SS SPDR S&P 500 ETF Tr | New | +555,000 | +$318M | 23.1% |
| IT Ishares Tr | New | +1,065,000 | +$235M | 17.1% |
| Galapagos Nv | Added | +15,000 | +$432K | 1.2% |
| Springworks Therapeutics Inc | Added | +12,500 | +$401K | 1.5% |
| Argenx Se | Added | +400 | +$217K | 2.1% |
| Churchill Capital Corp Vii | Exited | −548,000 | −$192K | — |
| Relay Therapeutics Inc | Added | +20,800 | +$147K | 0.8% |
| Ascendis Pharma A/s | Added | +800 | +$119K | 2.1% |
| Revolution Medicines Inc | Added | +2,496 | +$113K | 2.4% |
Showing the 10 largest of 15 changes.
Loading...
